115 related articles for article (PubMed ID: 19624835)
1. Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.
Casula M; Alaibac M; Pizzichetta MA; Bono R; Ascierto PA; Stanganelli I; Canzanella S; Palomba G; Zattra E; ; Palmieri G
BMC Dermatol; 2009 Jul; 9():7. PubMed ID: 19624835
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia.
James MR; Hayward NK; Dumenil T; Montgomery GW; Martin NG; Duffy DL
J Invest Dermatol; 2004 Oct; 123(4):760-2. PubMed ID: 15373782
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
4. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma.
McCarron SL; Bateman AC; Theaker JM; Howell WM
Int J Cancer; 2003 Nov; 107(4):673-5. PubMed ID: 14520709
[TBL] [Abstract][Full Text] [Related]
5. EGF gene polymorphism and the risk of incident primary melanoma.
Amend KL; Elder JT; Tomsho LP; Bonner JD; Johnson TM; Schwartz J; Berwick M; Gruber SB
Cancer Res; 2004 Apr; 64(8):2668-72. PubMed ID: 15087376
[TBL] [Abstract][Full Text] [Related]
6. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
7. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility.
Randerson-Moor JA; Gaut R; Turner F; Whitaker L; Barrett JH; Silva Idos S; Swerdlow A; Bishop DT; Bishop JA
J Invest Dermatol; 2004 Oct; 123(4):755-9. PubMed ID: 15373781
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between EGF 61A>G polymorphism and plasma EGF concentration in the STANISLAS family study.
Berrahmoune H; Herbeth B; Lamont JV; Masson C; FitzGerald SP; Visvikis-Siest S
J Invest Dermatol; 2007 Apr; 127(4):969-70. PubMed ID: 17170735
[No Abstract] [Full Text] [Related]
11. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
12. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
13. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
Araújo AP; Costa BM; Pinto-Correia AL; Fragoso M; Ferreira P; Dinis-Ribeiro M; Costa S; Reis RM; Medeiros R
World J Gastroenterol; 2011 Jan; 17(4):488-92. PubMed ID: 21274378
[TBL] [Abstract][Full Text] [Related]
14. Association between functional polymorphism in EGF gene and malignant melanoma.
Shahbazi M; Pravica V; Nasreen N; Fakhoury H; Fryer AA; Strange RC; Hutchinson PE; Osborne JE; Lear JT; Smith AG; Hutchinson IV
Lancet; 2002 Feb; 359(9304):397-401. PubMed ID: 11844511
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
16. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
17. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Oncol Res; 2008; 17(4):167-74. PubMed ID: 18773861
[TBL] [Abstract][Full Text] [Related]
18. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between polymorphisms of epidermal growth factor gene and silicosis].
Jiang DP; Wang CY; Fan XY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Nov; 31(11):820-4. PubMed ID: 24370290
[TBL] [Abstract][Full Text] [Related]
20. The EGF 61A/G polymorphism - a predictive marker for recurrence of liver metastases from colorectal cancer.
Kovar FM; Thallinger C; Marsik CL; Perkmann T; Puhalla H; Haslacher H; Wrba F; Wagner OF; Gruenberger T; Endler G
Wien Klin Wochenschr; 2009; 121(19-20):638-43. PubMed ID: 19921131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
